Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/05/20
Boston Scientific Rebounds From Q4 Sales Miss, Earns Relative Strength Rating UpgradeInvestors Business Daily • 01/30/20
Leading Medtech Stock Dives After Preliminary Sales Report DisappointsInvestors Business Daily • 01/14/20
How Does Abbott’s Revenue And Other Key Metrics Compare With That of Boston Scientific?Forbes • 12/31/19
Athenex Mixed Results, Boston Scientific Approval, And Other News: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 12/23/19
How Does Boston Scientific’s Revenue And Other Key Metrics Compare With That of Medtronic?Forbes • 12/06/19
Boston Scientific Corporation (BSX) Management presents at Piper Jaffray 31st Annual Healthcare Conference (Transcript)Seeking Alpha • 12/05/19